DEC 30, 2020 10:30 AM PST

Gene Therapy Cures Mice of Deafness

WRITTEN BY: Annie Lennon

Currently, around half a billion people suffer from hearing loss around the world. In about half of these cases, genetic mutations of one or more of around 100 different genes are thought to be the cause. Gene therapies thus hold obvious potential as a cure. And now, researchers from Tel Aviv University in Israel have successfully completed animal studies on a novel genetic-based treatment for the condition.

For the study, the researchers focused on genetic deafness caused by a mutation of the gene SYNE4. A rare condition, children who inherit the gene from both parents are born with normal hearing that gradually becomes weaker over the course of their childhood. This happens as the mutation causes mislocalization of cell nuclei in the hair cells inside the inner ear's cochlea (used to detect sound), and eventually leads to their degeneration and death. 

To see whether they could stop this process in its tracks, the researchers created a harmless synthetic virus capable of delivering a normal version of the SYNE4 gene to cells. They then injected this variant into the inner ear of mice carrying the mutated version soon after birth so it could enter their hair cells. 

As the mice grew older, the researchers monitored their hearing with physiological and behavioral tests. In the end, they found that mice treated soon after birth developed normal hearing with a sensitivity practically the same as that of healthy mice born without the mutation. Given this success, the researchers are now developing similar therapies that may be used for other mutations that cause deafness. 

"This is an important study that shows that inner ear gene therapy can be effectively applied to a mouse model of SYNE4 deafness to rescue hearing. The magnitude of hearing recovery is impressive.” says Professor Wade Chien from Johns Hopkins School of Medicine. 

“This study is a part of a growing body of literature showing that gene therapy can be successfully applied to mouse models of hereditary hearing loss, and it illustrates the enormous potential of gene therapy as a treatment for deafness."

 

Sources: Medical NewsTel Aviv University 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
DEC 31, 2020
Immunology
Arthritis Medication Resolves Previously Untreatable Skin Condition
DEC 31, 2020
Arthritis Medication Resolves Previously Untreatable Skin Condition
Bumpy, inflamed, ring-shaped lesions on the skin—granuloma annulare (GA) is a chronic, inflammatory skin condition ...
JAN 07, 2021
Drug Discovery & Development
Novel Drug To Treat Osteoporosis
JAN 07, 2021
Novel Drug To Treat Osteoporosis
A novel drug to treat osteoporosis comes with fewer side effects and may potentially be a new option for patients. The s ...
JAN 27, 2021
Drug Discovery & Development
Do Vaccines Work Against New Covid Variants?
JAN 27, 2021
Do Vaccines Work Against New Covid Variants?
The SARS-CoV-2 virus is mutating faster than scientists previously thought. As such, pharmaceutical companies are now sc ...
FEB 11, 2021
Drug Discovery & Development
Antibiotic-Use During Pregnancy
FEB 11, 2021
Antibiotic-Use During Pregnancy
A study published in the Archives of Disease in Childhood, shows that fetal exposure to antibiotics in mid to late pregn ...
MAR 30, 2021
Microbiology
A Marburg Virus Treatment Approach is Identified
MAR 30, 2021
A Marburg Virus Treatment Approach is Identified
Marburg virus causes severe hemorrhagic fever; its fatality ratio can be as high as 88 percent. Researchers may have now ...
APR 17, 2021
Drug Discovery & Development
Facebook AI May Speed up Cancer Drug Discovery
APR 17, 2021
Facebook AI May Speed up Cancer Drug Discovery
Facebook has claimed that its new artificial intelligence, known as 'Compositional Perturbation Autoencoder' (CP ...
Loading Comments...